TrianecT BV is an Academic Medical Center (AMC) and Neuromotion ventures spin-off of Wouter Potters, Jonathan Coutinho and Henk Marquering. TrianecT’s mission is to reduce unnecessary delays in the endovascular treatment of patients with stroke, resulting in a faster and better recovery with great economic benefit. To achieve this, TrianecT develops a medical device that can perform pre-hospital stroke triage by analyzing brain signals with algorithms, enabling ambulance personnel to bring each suspected stroke patient directly to the right hospital for the right treatment.

Categorieën